{"name":"Shandong Boan Biotechnology Co., Ltd","slug":"shandong-boan-biotechnology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"BA1106","genericName":"BA1106","slug":"ba1106","indication":"Other","status":"phase_1"},{"name":"LY01015","genericName":"LY01015","slug":"ly01015","indication":"Other","status":"phase_3"}]},{"name":"Oncology","slug":"oncology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"LY01008","genericName":"LY01008","slug":"ly01008","indication":"Non-small cell lung cancer","status":"phase_3"}]}],"pipeline":[{"name":"BA1106","genericName":"BA1106","slug":"ba1106","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"LY01008","genericName":"LY01008","slug":"ly01008","phase":"phase_3","mechanism":"LY01008 is a humanized monoclonal antibody that targets and inhibits PD-L1, blocking its interaction with PD-1 and B7.1 to enhance anti-tumor immune responses.","indications":["Non-small cell lung cancer","Other solid tumors (under investigation)"],"catalyst":""},{"name":"LY01015","genericName":"LY01015","slug":"ly01015","phase":"phase_3","mechanism":"LY01015 is a small molecule inhibitor that targets a specific molecular pathway involved in disease pathogenesis.","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwAJBVV95cUxQaW82RE9McWJyNWh3WTd5VTRkX2tRMVVXLXN3WndybUNlVWVpUGRmTGhUVTY1WFpuYVZueDBIRG1NeU9LcWlad1JhQnVSNENTR0c5b0tQNDVtUldtVVNjb2hYaVE2ZnZZMm1JZnkzWnBKZEp6ZFU0Umt3UG5jWlZVRHF6N19oT2Qtc2Jldkc2eHU4cW9hOWtvU3dBN1ZWbzVMT1ZiWFlGTlZ3czJyUlBHRUI0bWNIajNnbmx1dk4tYXdrZ0pnS2pFWGozZ1NDNHpkUGJMWmtnYXhVTXJXZWgxMUxYQnZsS3Zhc1hPR2VRdlo4LUh0YXlhbGdMM1Etb2ItTVRubU0wTnM0WXpwZFM2dE5WZWRyVWd0ckJNMWhhN2ZfTGplVmtobU10blNFU3NyWXhoMEZicENwNEczeHRINg?oc=5","date":"2026-04-02","type":"pipeline","source":"globenewswire.com","summary":"Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market - globenewswire.com","headline":"Programmed Death (PD)-1 Non-Small Cell Lung Cancer Market","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxPc0ZLSktDOElGVmRNMnVMVVF6TnBNZUZ4d21vZUl2UTJBZnk3UDFtc1JUQ21kck5JRUxLakdUc19xeWJHNmt4OWRoSWhIZjhkdE9fNGdWdFdGR1FseHpmN1lIbnVKVWZIdkpqdDgtZEQtVjlzc0VHVEdseElLTnJfZ2tERW80dEx4U3RWZDhKNzRTeUJCVnVhRktGT1R2czgwcS1mQ3pRV3ZwSWVaZzZtaG5PZjFheEVFeGwxMGtIbllCT0hJZ1Awa3RCTnpWdDdHZ0FrSjRMLURzVktZODhBMG8tTFc2VExlZTJHOEZOTWMxanhXYW0yMNIB_gFBVV95cUxOdzIxOFNPNC04bXFZVG1QQ3pwNkZtZFAtY0gzZHN0bE5DaGdhUEU2bUR0MXBpS1R2MVJ2LTU0M0U1NTV4LWl3ZkYtQTBSdEtWTkswc01MdXhaYXpHaUpZNTRtVmV1RjRCR3BVdjcydnI1QWM5b00taEVMV0dETWlKc1BHYVZuU3lHdlQyY2hZYlBJNW9KTWFvbmhLY1JrNE5fNHNUQ2ZUWHVIdzFScWJlQUdFSzRMZUNfN2VGS2JkR1VIX0FZZ01YaUZfSF9UOEgxT0xOZzNOTzBrZUVxTExDWnRncWpNSk9fUWZXWDhDNXhNUkEwdzk3bGNtRmhidw?oc=5","date":"2026-04-01","type":"earnings","source":"simplywall.st","summary":"Shandong Boan Biotechnology (SEHK:6955) Margin Compression Challenges Bullish Profitability Narratives - simplywall.st","headline":"Shandong Boan Biotechnology (SEHK:6955) Margin Compression Challenges Bullish Profitability Narratives","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-19","type":"regulatory","source":"EIN News","summary":"Hyaluronic Acid-Based Dermal Fillers Market 2026 growing due to rising demand for aesthetic treatments - EIN News","headline":"Hyaluronic Acid-Based Dermal Fillers Market 2026 growing due to rising demand for aesthetic treatments","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNYS1IdUV5MzhZend0eF9pSnQ3VjlQRGFjUUt4bl9DbU9Uc0l6dmtRQXpPZUZoWTgzeHhFdjdFakJNSURqdlhiaDUwc2pfT2hZOG1RQXZtb2NBQmpyZzllTHlreUlZbXg2NFd4eE10cERhZmd4bFNLLVV0TEFGaktldmpoSUpNcGQyQklTSllhVmF1a181RG95d3FGbTRZRng4WnFOUUVzejlTVnFWVG5oQjhLZnZCLUVxQjREMzJ2MjdnbGhjZ3NyN0ZNUERoNEtZRWx3NGotdU1MWV9MM2dTc2h4ajYwZF9Sa09fTVJrcjgtVUtHSEdKb9IB_gFBVV95cUxNblFTVlBoclAtV2tVdzl3bWtEVlg0eF96aTVkTUh0emluRng5QmdQZ2xVcHI5R2Fnczd3a2dlZC1aTUNiSjFoLWg0RnBmVGRuMWZ3eVRRNUkyLXVWUWhFUVFyYVEtNnpqNDJVaXZySzFKbVVnZl8xSDhrSFpjdDZDdHdJdUNIbWo4cTl4cFFPTFZmdHBieWZQUFl1R1pXVkE4dHk2ZTlnYmVINkc4MDRfOFhaTERCOVB4eVo0bHZITmJjWHEzZ0VVSmptQUU2NFNXcUxZMXZxX2o5cGFJUzlLbmcyWVRpbVZvNi1GTU9lNnRtM1hGOE9wdm5Ra1B5QQ?oc=5","date":"2025-12-03","type":"pipeline","source":"simplywall.st","summary":"Shandong Boan Biotechnology Co., Ltd. (HKG:6955) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Correct The Share Price In The Future? - simplywall.st","headline":"Shandong Boan Biotechnology Co., Ltd. (HKG:6955) Stock's Been Sliding But Fundamentals Look Decent: Will The Market Corr","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTFA3UEozQnJoNEpGcnk3Mzk3al9QSlhhTjVTbGxIdnJyemVvRFNTdjVINkc3LWJ0ZmZCMVhsb2hmUllmWksyRHVxUlNOakZ2WDhiTnJqTm4yczVIZzJUN3poaDZB?oc=5","date":"2025-06-12","type":"pipeline","source":"Global Times","summary":"China's innovative drug companies rallying on stock market, driven by strength in global market penetration - Global Times","headline":"China's innovative drug companies rallying on stock market, driven by strength in global market penetration","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivAFBVV95cUxQaWNJa2hJZjNSSFEzY1ZYbmFveTdSeTUxZVJwS2ZxYXNPTjFwVExnWjVfQXFtbFNxcU9HYjNYSmFNSG83ajNfRHotSTdvUzlBSlJmdVZfLWhZVmxVR19ZR0s4R0pWd0VRRXNuTjRiNDJHMENIeGxJd2dvVjVUWDRaV1RuSnhZQ214SjFkUGd6VHhyTW1oT0VhN3pxMTlaSDk0RUViaUVqYWQyeGhpTFpQbGRCbEU5bTFkYV9ZSQ?oc=5","date":"2025-03-31","type":"regulatory","source":"pharmacytimes.com","summary":"FDA Grants BA1302 Orphan Drug Designation for Squamous NSCLC and Pancreatic Cancer - pharmacytimes.com","headline":"FDA Grants BA1302 Orphan Drug Designation for Squamous NSCLC and Pancreatic Cancer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxPamI0dDdoRkVUeDRSY0Rrem9HOU9FY3IzbG9FdXJIZk5yMXdJZFg4a18ySk1tbHlMbHpLelM5ZUkzOXdzWXZ1WE40OE11a0F4a0JwbWdIcGMtem95Q2k2X1o2NGszMGItSGQtYXFXajY2WFB6emliQ09zTjl0a1VZTUdPWkk3dE9Hd25lMmdyOXFaa3VpNzRPc0lkVFJpV3VqSnc?oc=5","date":"2024-04-09","type":"patent","source":"BioWorld News","summary":"More biosimilars from China, US encroach on Amgen’s denosumab - BioWorld News","headline":"More biosimilars from China, US encroach on Amgen’s denosumab","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiWkFVX3lxTFBJbU12c1djUTFNYk9kZmlOQkRFdm52d1czUlNpUDNvNTdKNWcwWTBQV2ItMVJudVIxbGJhUjNUX09jeGVKdV9za2VOa0JzYndQQjlqRzFPS2d5UQ?oc=5","date":"2022-12-29","type":"pipeline","source":"TradingView","summary":"6955 Stock Price and Chart — HKEX:6955 - TradingView","headline":"6955 Stock Price and Chart — HKEX:6955","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxObFo5cFQxQUN6ZktMTXdIQnh5aGRuSUkxLVg3Y0ZBY0FrcmZ4SXFYR1RQTFVFc2Fnd01rTGdRY2RzSkhPbFN3OW5lYTMxMVBsSG0waUxTb2laRF9yV0k2TDdpVjkwOHlZN2o0V05VT01FU193cDF5amZUUkVibDhtRm1kQWhuTUZxM1E?oc=5","date":"2022-12-12","type":"pipeline","source":"thestandard.com.hk","summary":"Pharma firm in $500m placement - thestandard.com.hk","headline":"Pharma firm in $500m placement","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxPb0hoc05sM2Y2bDJEYXZyMktyU0VScHpabVB3cnpyZjEzc2dPUzJyYXF4cjg1aXJHLXBIQjFJcV84bU55YTlEY2Z4czJWeENWemIzc3ZHM0xYNmZZOVJxVHNnZi1VUnU2QXlWX3hySTQxMllnWDhDb21PejQ1d0FKNndOZDhJRGZQMW9xNzJHLUFRTHF0bUtfbWx3?oc=5","date":"2017-11-05","type":"pipeline","source":"hkex.com.hk","summary":"China Dimension - hkex.com.hk","headline":"China Dimension","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_1":1,"phase_3":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}